Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastasis From Malignant Tumor of Prostate”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01091103
What this trial is testing

Determine Effect of Enzalutamide (MDV3100) on the Androgen Signaling Pathway in Correlation With the Anti-tumor Effects of Enzalutamide

Who this might be right for
Metastatic Progressive Castration-resistant Prostate Cancer
Pfizer 60
Testing effectiveness (Phase 2)Looking for participantsNCT06655259
What this trial is testing

Combination of TURP and Standard Systemic Therapy for MPCa

Who this might be right for
Metastatic Prostate Cancer
Fudan University 200
Testing effectiveness (Phase 2)Ended earlyNCT05917470
What this trial is testing

A Clinical Study of ONCT-534 in Subjects With Metastatic Castration-resistant Prostate Cancer.

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Oncternal Therapeutics, Inc 21
Early research (Phase 1)Study completedNCT00415779
What this trial is testing

ZANTE: Zometa and Taxotere in Hormone Refractory Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
National Cancer Institute, Naples 36
Testing effectiveness (Phase 2)Study completedNCT04925648
What this trial is testing

Psma Intensity Can be Altered by Androgen and Phospho-SrC Obstruction

Who this might be right for
Metastatic Prostate Cancer
St Vincent's Hospital, Sydney 4
Not applicableLooking for participantsNCT06171139
What this trial is testing

Tumor Genomic Pre-test Counseling Tool for Black or African-American Men With Prostate Cancer

Who this might be right for
Prostate CancerProstate Cancer Metastatic
University of California, San Francisco 80
Large-scale testing (Phase 3)Study completedNCT01394263
What this trial is testing

Study of Histrelin Subdermal Implant in Patients With Prostate Cancer

Who this might be right for
Prostate CancerAdenocarcinoma of the Prostate
Endo USA Inc., a Keenova Therapeutics Company 59
Testing effectiveness (Phase 2)WithdrawnNCT02793765
What this trial is testing

Docetaxel Followed by Provenge in Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
The University of Texas Health Science Center, Houston
Testing effectiveness (Phase 2)Study completedNCT00116155
What this trial is testing

Trial of IV Injection of CV787 in Hormone Refractory Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Cell Genesys
Testing effectiveness (Phase 2)Study completedNCT00417274
What this trial is testing

Quinacrine Treatment in Patients With Androgen-Independent Prostate Cancer

Who this might be right for
Prostatic Cancer
Cleveland BioLabs 31
Not applicableLooking for participantsNCT07302763
What this trial is testing

Four-Timepoint Multi-tracer PET Imaging to Characterize Metastatic prOstate Cancer Heterogeneity

Who this might be right for
mCRPC (Metastatic Castration-resistant Prostate Cancer)
Frederic Pouliot 45
Large-scale testing (Phase 3)Looking for participantsNCT03903835
What this trial is testing

ProBio: A Biomarker Driven Study in Patients With Metastatic Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer (mCRPC)Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
Karolinska Institutet 750
Not applicableStudy completedNCT04400656
What this trial is testing

PROState Pathway Embedded Comparative Trial

Who this might be right for
Prostate CancerNon-metastatic Prostate CancerMetastatic Prostate Cancer+3 more
Imperial College London 139
Testing effectiveness (Phase 2)WithdrawnNCT04483414
What this trial is testing

68Ga PSMA-11 PET/CT in Recurrent Prostate Cancer

Who this might be right for
Prostate CancerProstate Cancer MetastaticProstate Cancer Metastatic to Bone
Dana Mathews
Testing effectiveness (Phase 2)Study completedNCT01815515
What this trial is testing

Evaluation of 18F-DCFBC PSMA-based PET Imaging for Detection of Metastatic Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 22
Testing effectiveness (Phase 2)Study completedNCT01083368
What this trial is testing

Temsirolimus and Bevacizumab in Hormone-Resistant Metastatic Prostate Cancer That Did Not Respond to Chemotherapy

Who this might be right for
Prostate Cancer
Case Comprehensive Cancer Center 22
Large-scale testing (Phase 3)Looking for participantsNCT06112990
What this trial is testing

Creatine Supplementation and Resistance Training to Preserve Muscle Mass and Attenuate Cancer Progression

Who this might be right for
Metastatic Prostate Cancer
University of Utah 200
Testing effectiveness (Phase 2)Active Not RecruitingNCT03361735
What this trial is testing

Radium Ra 223 Dichloride, Hormone Therapy and Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Adenocarcinoma
City of Hope Medical Center 25
Testing effectiveness (Phase 2)WithdrawnNCT01658527
What this trial is testing

TAK-700 in Castration Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Not applicableStudy completedNCT03486886
What this trial is testing

PSMA-PET Imaging in Patients With Metastatic Prostate Cancer: Institutional Evaluation of Detection Yield Performance and Reproducibility

Who this might be right for
Prostate Cancer
Centre hospitalier de l'Université de Montréal (CHUM) 29
Next Page